KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Consolidated Net Income: 2009-2025

Historic Consolidated Net Income for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $1.6 billion.

  • Thermo Fisher Scientific's Consolidated Net Income fell 1.46% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year increase of 5.76%. This contributed to the annual value of $6.4 billion for FY2024, which is 6.09% up from last year.
  • Thermo Fisher Scientific's Consolidated Net Income amounted to $1.6 billion in Q3 2025, which was up 0.12% from $1.6 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Consolidated Net Income registered a high of $2.3 billion during Q2 2021, and its lowest value of $1.3 billion during Q1 2024.
  • In the last 3 years, Thermo Fisher Scientific's Consolidated Net Income had a median value of $1.6 billion in 2025 and averaged $1.6 billion.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first spiked by 196.57% in 2021, then slumped by 41.18% in 2023.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's Consolidated Net Income stood at $1.7 billion in 2021, then declined by 3.32% to $1.6 billion in 2022, then grew by 0.19% to $1.6 billion in 2023, then increased by 11.45% to $1.8 billion in 2024, then declined by 1.46% to $1.6 billion in 2025.
  • Its Consolidated Net Income stands at $1.6 billion for Q3 2025, versus $1.6 billion for Q2 2025 and $1.5 billion for Q1 2025.